Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GIDEON LEWIS

Allopathic & Osteopathic Physicians Family Medicine Adult Medicine

NPI
1508845116
CMS profile
249846
Location
WINTER PARK, FL

General Payments · PY2018–2024

$1,686.57

  • Reported across 78 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$366.79

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $366.79 15

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $126.38 5
PY2019 $83.69 4
PY2020 $259.53 15
PY2021 $246.26 14
PY2022 $420.61 17
PY2023 $183.31 8
PY2024 $366.79 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $43.42 02/07/2024 Food and Beverage Undisputed 01/23/2026 1104412215 CMS
AstraZeneca Pharmaceuticals LP $14.13 04/10/2024 Food and Beverage Undisputed 01/23/2026 1105548283 CMS
AstraZeneca Pharmaceuticals LP $19.69 04/19/2024 Food and Beverage Undisputed 01/23/2026 1105323700 CMS
AstraZeneca Pharmaceuticals LP $22.22 05/08/2024 Food and Beverage Undisputed 01/23/2026 1104206251 CMS
AstraZeneca Pharmaceuticals LP $13.97 08/14/2024 Food and Beverage Undisputed 01/23/2026 1105669931 CMS
AstraZeneca Pharmaceuticals LP $19.46 08/23/2024 Food and Beverage Undisputed 01/23/2026 1105604547 CMS
AstraZeneca Pharmaceuticals LP $15.05 09/03/2024 Food and Beverage Undisputed 01/23/2026 1104236403 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.08 03/26/2024 Food and Beverage Undisputed 01/23/2026 1118038462 CMS
GlaxoSmithKline, LLC. $16.26 08/21/2024 Food and Beverage Undisputed 01/23/2026 1116662555 CMS
GlaxoSmithKline, LLC. $22.83 11/06/2024 Food and Beverage Undisputed 01/23/2026 1116147789 CMS
Lilly USA, LLC $17.29 05/15/2024 Food and Beverage Undisputed 01/23/2026 1135009487 CMS
Novo Nordisk Inc $20.85 03/14/2024 Food and Beverage Undisputed 01/23/2026 1097533245 CMS
Paratek Pharmaceuticals, Inc. $14.62 02/22/2024 Food and Beverage Undisputed 01/23/2026 1113908176 CMS
Stryker Corporation $33.45 04/16/2024 Food and Beverage Undisputed 01/23/2026 1119894244 CMS
Zimmer Biomet Holdings, Inc. $67.47 11/05/2024 Food and Beverage Undisputed 01/23/2026 1155025224 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.